AIM: Development of multifunctional and well-dispersed hollow mesoporous silica nanoparticles (HMSNs) for tumor vasculature targeted drug delivery and PET imaging. MATERIALS & METHODS: Amine functionalized HMSNs (150-250 nm) were conjugated with a macrocyclic chelator, (S)-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triaceticacid (NOTA), PEGylated and loaded with antiangiogenesis drug, Sunitinib. Cyclo(Arg-Gly-Asp-D-Tyr-Lys) (cRGDyK) peptide was attached to the nanoconjugate and radiolabeled with (64)Cu for PET imaging. RESULTS: (64)Cu-NOTA-HMSN-PEG-cRGDyK exhibited integrin-specific uptake both in vitro and in vivo. PET results indicated approximately 8% ID/g uptake of targeted nanoconjugates in U87MG tumors, which correlated well with ex vivo and histological analyses. Enhanced tumor-targeted delivery of sunitinib was also observed. CONCLUSION: We successfully developed tumor vasculature targeted HMSNs for PET imaging and image-guided drug delivery.
AIM: Development of multifunctional and well-dispersed hollow mesoporoussilica nanoparticles (HMSNs) for tumor vasculature targeted drug delivery and PET imaging. MATERIALS & METHODS:Amine functionalized HMSNs (150-250 nm) were conjugated with a macrocyclic chelator, (S)-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triaceticacid (NOTA), PEGylated and loaded with antiangiogenesis drug, Sunitinib. Cyclo(Arg-Gly-Asp-D-Tyr-Lys) (cRGDyK) peptide was attached to the nanoconjugate and radiolabeled with (64)Cu for PET imaging. RESULTS: (64)Cu-NOTA-HMSN-PEG-cRGDyK exhibited integrin-specific uptake both in vitro and in vivo. PET results indicated approximately 8% ID/g uptake of targeted nanoconjugates in U87MGtumors, which correlated well with ex vivo and histological analyses. Enhanced tumor-targeted delivery of sunitinib was also observed. CONCLUSION: We successfully developed tumor vasculature targeted HMSNs for PET imaging and image-guided drug delivery.
Authors: Hao Hong; Yunan Yang; Yin Zhang; Jonathan W Engle; Todd E Barnhart; Robert J Nickles; Bryan R Leigh; Weibo Cai Journal: Eur J Nucl Med Mol Imaging Date: 2011-03-04 Impact factor: 9.236
Authors: Xiaoyuan Chen; Shuang Liu; Yingping Hou; Michel Tohme; Ryan Park; James R Bading; Peter S Conti Journal: Mol Imaging Biol Date: 2004 Sep-Oct Impact factor: 3.488
Authors: Anthony J Di Pasqua; Krishna K Sharma; Yan-Li Shi; Bonnie B Toms; Wayne Ouellette; James C Dabrowiak; Tewodros Asefa Journal: J Inorg Biochem Date: 2008-01-09 Impact factor: 4.155
Authors: M Gary-Bobo; O Vaillant; M Maynadier; I Basile; A Gallud; K El Cheikh; E Bouffard; A Morère; X Rébillard; P Puche; P Nirdé; M Garcia Journal: Curr Med Chem Date: 2013 Impact factor: 4.530
Authors: Sooyeon Kwon; Rajendra K Singh; Roman A Perez; Ensanya A Abou Neel; Hae-Won Kim; Wojciech Chrzanowski Journal: J Tissue Eng Date: 2013-09-03 Impact factor: 7.813
Authors: Wei Chen; Chi-An Cheng; Emily D Cosco; Shyam Ramakrishnan; Jakob G P Lingg; Oliver T Bruns; Jeffrey I Zink; Ellen M Sletten Journal: J Am Chem Soc Date: 2019-08-02 Impact factor: 15.419